Impact of the Innovative Medicines Initiative on vaccine development

被引：0
|
作者：
Philippe Denoel
Patricia Londoño-Hayes
Magda Chlebus
Magdalena Rodriguez de Azero
机构：
[1] GSK,
[2] Sanofi Pasteur,undefined
[3] European Federation of Pharmaceutical Industries and Associations (EFPIA),undefined
[4] Vaccines Europe/EFPIA,undefined
来源：
Nature Reviews Drug Discovery | 2018年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Since its launch a decade ago, the European Innovative Medicines Initiative (IMI), a leading public–private partnership in life sciences, has catalysed scientific breakthroughs and the development of strategies to address complex challenges in various biomedical fields. Here, we discuss the progress of IMI projects related to vaccine research and development.
引用
收藏
页码：769 / 770
页数：1
相关论文
共 50 条
  • [1] Impact of the Innovative Medicines Initiative on vaccine development
    Denoel, Philippe
    Londono-Hayes, Patricia
    Chlebus, Magda
    de Azero, Magdalena Rodriguez
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (11) : 769 - 770
  • [2] Scientific Advances in Diabetes: The Impact of the Innovative Medicines Initiative
    Brito, Maria de Fatima
    Torre, Carla
    Silva-Lima, Beatriz
    [J]. FRONTIERS IN MEDICINE, 2021, 8
  • [3] Will the Innovative Medicines Initiative really deliver innovative medicines?
    Wilkinson, Emma
    [J]. MOLECULAR ONCOLOGY, 2008, 2 (03) : 203 - 205
  • [4] Reflections on the Innovative Medicines Initiative
    Michel Goldman
    [J]. Nature Reviews Drug Discovery, 2011, 10 : 321 - 322
  • [5] Reflections on the Innovative Medicines Initiative
    Goldman, Michel
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (05) : 321 - 322
  • [6] INNOVATIVE MEDICINES INITIATIVE: THE SPRINTT PROJECT
    Marzetti, E.
    Calvani, R.
    Landi, F.
    Hoogendijk, E.
    Fougere, B.
    Vellas, B.
    Pahor, M.
    Bernabei, R.
    Cesari, M.
    [J]. JOURNAL OF FRAILTY & AGING, 2015, 4 (04): : 207 - 208
  • [7] Innovative Medicines Initiative and antibiotic resistance
    Kostyanev, Tarnishiv
    Bonten, Marc J. M.
    O'Brien, Seamus
    Goossens, Herman
    [J]. LANCET INFECTIOUS DISEASES, 2015, 15 (12): : 1373 - 1375
  • [8] Erratum: Reflections on the Innovative Medicines Initiative
    Michel Goldman
    [J]. Nature Reviews Drug Discovery, 2011, 10 : 471 - 471
  • [9] The Rational Use of Animals in Drug Development: Contribution of the Innovative Medicines Initiative
    Gunn, Magda
    Vaudano, Elisabetta
    Goldman, Michel
    [J]. ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2012, 40 (06): : 307 - 312
  • [10] Benchmarking the scientific output of the Innovative Medicines Initiative
    Gunn, Magda
    Lim, Mark
    Cross, Didi
    Goldman, Michel
    [J]. NATURE BIOTECHNOLOGY, 2015, 33 (08) : 811 - 812
12345